elsiglutide
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2012 (NCT01543451)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
GLP2R agonist
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108318 ↗
Also known as
- elsiglutide
- elsiglutide
- zp-1846
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02383810 | Phase 2 | Feb 1, 2015 | Chiltern International, Helsinn |
| NCT01543451 | Phase 2 | Feb 1, 2012 | Helsinn |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Helsinn | For profit | 2 | 2 | 1 | 2012 |
| Chiltern International | For profit | 1 | 0 | 1 | 2015 |
2 organizations
Page 1 / 1